HealthyWay Inc (2587) Fair Value & Analysis
Healthcare · HK · Market cap HK$2.1B
Fair value as of: Aug 13, 2026
From 24 valuation models · updated 3 days ago
Fair value updated Aug 13, 2026, revised from HK$1.48 to HK$1.63 (+10.1%) since Aug 6, 2026. Share price −8.1% over the past month.
A solid business, but screening 20% overvalued on our models.
What matters now
- Solid but not exceptional quality (65/100) and above fair value, neither a clear bargain nor a standout compounder.
- Our model range runs from HK$1.22 (bear) to HK$2.04 (bull), base HK$1.63. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 65/100 (solid quality) with high evidence: the data supports the verdict.
Price vs Fair Value (19 months)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
19‑month range HK$2.03 – HK$60.00 · fair‑value band HK$1.22 – HK$2.04 · the HK$2.03 price screens above the HK$1.63 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
HealthyWay Inc (2587) currently trades at HK$2.03, while our model-based Fair Value estimate is HK$1.63, implying the stock looks roughly 19.7% overvalued today. The Quality Score stands at 65/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, HealthyWay Inc generated revenue of HK$1.6B at a net margin of 3.6%. Revenue grew 77.3% year over year. It earns a return on equity of 21.1%. The stock trades on a trailing P/E of 34.0 (as of Jul 2, 2026). Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$1.22 (bear case) to HK$2.04 (bull case); at HK$2.03, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at -64% fair-value upside, at -20%, 2587 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth Earnings (HK$2.85) versus Asset-Based (HK$0.2100). Highest evidence: Growth DCF (80).
Notify me when 2587 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 65 · Market factors (momentum, volatility) 0
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
HealthyWay Inc., an investment holding company, provides corporate and digital marketing, and health and medical services in the People's Republic of China.
Full company description
HealthyWay Inc., an investment holding company, provides corporate and digital marketing, and health and medical services in the People's Republic of China. The company offers medical support services for individuals to manage their everyday health and wellness through health membership schemes and other medical support services, including medical consultation services, and supporting services to hospitals. It also involved in the provision of healthcare service packages; and pharmaceutical sales business. In addition, the company offers content services, including wellness content, precision content, and RWS support services; information technology services to corporate and institutional customers; and digital marketing services to advertisers through publishing and posting original marketing articles and brand-building advertisements through platform and other third-party online media channels. Further, the company operates Yihu.com, a health and medical platform. HealthyWay Inc. was founded in 2001 and is headquartered in Fuzhou, the People's Republic of China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
HealthyWay Inc reported revenue of HK$1.6B in FY2025 versus HK$431M in FY2021, a compound +38.0%/yr. Reported net income was HK$55.7M in FY2025.
2587 screens 20% overvalued. Compare with Veeva Systems Inc →
Peer Group
Health Information Services · 125 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Health Information Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $241.51 | $91.49 | -62% |
| Pro Medicus Limited PME | A$183.71 | A$23.74 | -87% |
| BrightSpring Health Services, Inc BTSG | $59.68 | $21.31 | -64% |
| HealthEquity, Inc HQY | $105.50 | $56.63 | -46% |
| Hinge Health, Inc HNGE | $86.32 | $24.03 | -72% |
| 10x Genomics, Inc TXG | $58.48 | $17.18 | -71% |
| Waystar Holding WAY | $24.54 | $12.86 | -48% |
| XtalPi Holdings 2228 | HK$8.19 | HK$1.04 | -87% |
| Doximity, Inc DOCS | $24.99 | $25.91 | +4% |
| Privia Health Group PRVA | $21.54 | $5.26 | -76% |
Compare HealthyWay Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is HealthyWay Inc (2587) overvalued or undervalued?
What is the fair value of 2587?
What is the quality score of 2587?
What is the revenue of HealthyWay Inc (2587)?
What is the net profit margin of 2587?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track HealthyWay Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.